etiron has been researched along with Cardiovascular Diseases in 1 studies
etiron: a nitric oxide synthase inhibitor; RN given refers to parent cpd; structure
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse events were recorded from study drug initiation through 30 days after the operation." | 2.73 | Nitric oxide synthase inhibitor (MTR-105) during open-heart surgery. A pilot double-blind placebo-controlled study of hemodynamic effects and safety. ( Borer, JS; Ciubotaru, A; Manolache, G; Sasson, L; Schachner, A; Ureche, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasson, L | 1 |
| Ureche, A | 1 |
| Manolache, G | 1 |
| Ciubotaru, A | 1 |
| Borer, JS | 1 |
| Schachner, A | 1 |
1 trial available for etiron and Cardiovascular Diseases
| Article | Year |
|---|---|
Nitric oxide synthase inhibitor (MTR-105) during open-heart surgery. A pilot double-blind placebo-controlled study of hemodynamic effects and safety.
Topics: Adult; Aged; Blood Pressure; Cardiac Surgical Procedures; Cardiovascular Diseases; Double-Blind Meth | 2008 |